dr. A. Wunderink

No picture available
E-mail:
a.wunderink umcg.nl

Research

  1. 2021
  2. 2020
  3. 2019
  4. Malda, A., Boonstra, N., Barf, H., de Jong, S., Aleman, A., Addington, J., Pruessner, M., Nieman, D., de Haan, L., Morrison, A., Riecher-Roessler, A., Studerus, E., Ruhrmann, S., Schultze-Lutter, F., An, S. K., Koike, S., Kasai, K., Nelson, B., McGorry, P., ... Pijnenborg, G. H. M. (2019). Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis. Frontiers in Psychiatry, 10, [345]. https://doi.org/10.3389/fpsyt.2019.00345
  5. 2018
  6. Swildens, W. E., Visser, E., Bahler, M., Bruggeman, R., Delespaul, P., van der Gaag, M., de Haan, L., Keet, R., Nijssen, Y., van Os, J., Pijnenborg, G. M., Slooff, C., de Vos, A., van Weeghel, J., Wunderink, L., Mulder, C. L., & Wiersma, D. (2018). Functional Recovery of Individuals With Serious Mental Illnesses: Development and Testing of a New Short Instrument for Routine Outcome Monitoring. Psychiatric Rehabilitation Journal, 41(4), 341-350. https://doi.org/10.1037/prj0000320
  7. Weller, A., Gleeson, J., Alvarez-Jimenez, M., McGorry, P., Nelson, B., Allott, K., Bendall, S., Bartholomeusz, C., Koval, P., Harrigan, S., O'Donoghue, B., Fornito, A., Pantelis, C., Paul Amminger, G., Ratheesh, A., Polari, A., Wood, S. J., van der El, K., Ellinghaus, C., ... Killackey, E. (2018). Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol. Early intervention in psychiatry. https://doi.org/10.1111/eip.12769
  8. 2017
  9. Ising, H. K., Lokkerbol, J., Rietdijk, J., Dragt, S., Klaassen, R. M. C., Kraan, T., Boonstra, N., Nieman, D. H., van den Berg, D. P. G., Linszen, D. H., Wunderink, L., Veling, W., Smit, F., & van der Gaag, M. (2017). Cost-effectiveness of Cognitive Behavior Therapy for Preventing First-episode Psychosis in People with Ultra-High Risk. Journal of Mental Health Policy and Economics, 20, S17-S17.
  10. Kraan, T. C., Ising, H. K., Fokkema, M., Velthorst, E., van den Berg, D. P. G., Kerkhoven, M., Veling, W., Smit, F., Linszen, D. H., Nieman, D. H., Wunderink, L., Boonstra, N., Klaassen, R. M. C., Dragt, S., Rietdijk, J., de Haan, L., & van der Gaag, M. (2017). The effect of childhood adversity on 4-year outcome in individuals at ultra high risk for psychosis in the Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial. Psychiatry Research, 247, 55-62. https://doi.org/10.1016/j.psychres.2016.11.014
  11. 2016
  12. Ising, H., Smit, F., Ruhrmann, S., Veling, W., Rietdijk, J., Dragt, S., Klaassen, R., Boonstra, N., Nieman, D., Wunderink, L., Linszen, D., & Van Der Gaag, M. (2016). Improving outcome with CBTuhr: Costeffectiveness and profiling after 4-years. 76. https://doi.org/10.1111/eip.12396
  13. Ising, H., Smit, F., Ruhrmann, S., Veling, W., Rietdijk, J., Dragt, S., Klaassen, R., Boonstra, N., Nieman, D., Wunderink, L., Linszen, D., & van der Gaag, M. (2016). Improving Outcome with CBTuhr: Cost-effectiveness and Profiling After 4-Years. Early intervention in psychiatry, 10, 76-76.
  14. Ising, H. K., Kraan, T., Rietdijk, J., Dragt, S., Klaassen, R. M. C., Boonstra, N., Nieman, D. H., Willebrands-Mendrik, M., van den Berg, D. P. G., Linszen, D. H., Wunderink, L., Veling, W., Smit, F., & van der Gaag, M. (2016). Four-Year Cost-effectiveness of Cognitive Behavior Therapy for Preventing First-episode Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial. Schizophrenia Bulletin, 42(5), 1243-1252. https://doi.org/10.1093/schbul/sbw018
  15. Alvarez-Jimenez, M., O'Donoghue, B., Thompson, A., Gleeson, J. F., Bendall, S., Gonzalez-Blanch, C., Killackey, E., Wunderink, L., & McGorry, P. D. (2016). Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era. Cns Drugs, 30(5), 357-368. https://doi.org/10.1007/s40263-016-0331-x
  16. 2015
  17. 2014
  18. 2013
  19. 2012
  20. Ising, H. K., Veling, W., Loewy, R. L., Rietveld, M. W., Rietdijk, J., Dragt, S., Klaassen, R. M. C., Nieman, D. H., Wunderink, L., Linszen, D. H., & van der Gaag, M. (2012). The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population. Schizophrenia Bulletin, 38(6), 1288-1296. https://doi.org/10.1093/schbul/sbs068
  21. Ising, H., Veling, W., Loewy, R., Rietveld, M., Rietdijk, J., Dragt, S., Klaassen, R., Nieman, D., Wunderink, L., Linszen, D., & Van Der Gaag, M. (2012). Psychosis risk screening in routine mental health care. 1. https://doi.org/10.1111/j.1751-7893.2012.00392.x
Previous 1 2 Next

ID: 226476